首页> 外文期刊>Spine >B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.
【24h】

B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft.

机译:与自体移植相比,陶瓷颗粒上的B2A肽增强了兔后外侧脊柱融合。

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY DESIGN: Six groups of 10 animals underwent single level, uninstrumented posterolateral lumbar fusions. Graft sites were implanted with autologous bone, autologous bone plus B2A coated granules with concentrations of 0-, 50-, 100-, or 300 microg/mL, or no graft material. Explanted motion segments were analyzed by Faxitron radiographs, computerized tomography (CT), manual palpation, and histology. OBJECTIVE: The synthetic peptide B2A2-K-NS (B2A) was evaluated as a novel agent for augmenting spinal fusion in a posterolateral, noninstrumented rabbit lumbar spine fusion model. SUMMARY OF BACKGROUND DATA: There have been many efforts to increase the rate of posterolateral spinal fusion while, at the same time minimizing, use of autologous bone with its inherent harvest morbidity. METHODS: B2A coated ceramic granules (0-, 50-, 100-, and 300 microg/mL) were mixed 1:1 with autogenous iliac crest bone and implanted. Autogenous bone alone was used as a positive control. Fusion was assessed at 6 weeks via radiographs and manual palpation. These results were confirmed with histology and CT. RESULTS: Fusion results from palpation and radiographic evaluations were similar. CT and histology confirmed bridging bone across the transverse processes for fused spines. The highest fusion rates were observed in the 100 mug B2A/mL group-89% in comparison to 33% for uncoated granules (0 microg B2A/mL) and 63% for autograft alone. These differences were statistically significant. CONCLUSION: All investigated B2A concentrations demonstrated increased fusion rates. Fusion masses resulting from the implantation of 100 mug B2A/mL granules demonstrated new woven bone: fused to the transverse processes, within granule pores, bridging bone across the transverse processes, and bridging residual bone graft and granules. It was concluded that each investigated concentration of B2A coated granules in a 1:1 mixture with autograft increased fusion rates in comparison to controls in this rabbit model.
机译:研究设计:六组,每组10只动物,进行单水平,非器械后外侧腰椎融合术。移植部位植入自体骨,自体骨以及B2A包被的0-,50-,100-或300 microg / mL浓度的颗粒,或无移植物。通过Faxitron射线照片,计算机断层扫描(CT),手动触诊和组织学分析外植的运动节段。目的:合成肽B2A2-K-NS(B2A)被评估为一种在后外侧非器械兔腰椎融合模型中增强脊柱融合的新型药物。背景技术概述:已经进行了许多努力来提高后外侧脊柱融合的速度,同时将自体骨及其固有的发病率降至最低。方法:将B2A涂层陶瓷颗粒(0、50、100和300 microg / mL)与自体骨1:1混合并植入。单独使用自体骨作为阳性对照。通过X光片和人工触诊评估融合6周。组织学和CT证实了这些结果。结果:触诊和影像学评估的融合结果相似。 CT和组织学证实,在融合棘突的整个横突中桥接骨。在100杯B2A / mL组中观察到最高的融合率,为89%,而未包衣颗粒(0微克B2A / mL)为33%,仅自体移植为63%。这些差异具有统计学意义。结论:所有研究的B2A浓度均显示融合速率增加。植入100杯B2A / mL颗粒产生的融合块显示出新的编织骨:在颗粒孔内融合到横向过程中,桥接横向过程中的骨,以及桥接残余的骨移植物和颗粒。得出的结论是,与该兔模型中的对照相比,自体移植的1:1混合物中B2A包衣颗粒的每种浓度研究均可提高融合率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号